Aclaris Therapeutics

(NASDAQ) ACRS

Current Price$4.82

Market Cap$710.89M

Since IPO (2015)-54%

5 Year-76%

1 Year+317%

1 Month+31%

Aclaris Therapeutics Financials at a Glance

Market Cap

$710.89M

Revenue (TTM)

$8.37M

Net Income (TTM)

$69.66M

EPS (TTM)

$-0.56

P/E Ratio

-9.08

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$4.82

Volume

94,547

Open

$5.14

Price

$4.82

Volume

94,547

Open

$5.14

Previous Close

$4.82

Daily Range

$4.79 - $5.14

52-Week Range

$1.16 - $5.14

Dividend

$0.00

Beta (Volatility)

1.08 (Average)

Price

$4.82

Volume

94,547

Open

$5.14

Previous Close

$4.82

Daily Range

$4.79 - $5.14

52-Week Range

$1.16 - $5.14

ACRS News

Two people seated at a lab desk featuring a PC screen and microscope

ACRS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aclaris Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Neal S. Walker, PhD, MBA

Website

www.aclaristx.com

Headquarters

Wayne, PA 19087, US

ACRS Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-10%

Net Income Margin

-8%

Return on Equity

-48%

Return on Capital

-47%

Return on Assets

-35%

Earnings Yield

-11.01%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$710.89M

Shares Outstanding

139.66M

Volume

94.55K

Avg. Volume

1.87M

Financials (TTM)

Gross Profit

$5.74M

Operating Income

$76.38M

EBITDA

$64.47M

Operating Cash Flow

$47.11M

Capital Expenditure

$111.00K

Free Cash Flow

$47.11M

Cash & ST Invst.

$90.75M

Total Debt

$2.12M

Aclaris Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.00M

+37.2%

Gross Profit

$1.60M

+68.7%

Gross Margin

80.21%

N/A

Market Cap

$710.89M

N/A

Market Cap/Employee

$11.65M

N/A

Employees

N/A

Net Income

$19.82M

-31.4%

EBITDA

$22.19M

-25.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$103.43M

-1.8%

Accounts Receivable

$4.81M

+1825.6%

Inventory

$0.00

N/A

Long Term Debt

$1.42M

N/A

Short Term Debt

$569.00K

N/A

Return on Assets

-35.06%

N/A

Return on Invested Capital

-46.97%

N/A

Free Cash Flow

$18.15M

-38.5%

Operating Cash Flow

$18.15M

-39.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BIOABioAge Labs, Inc.

BIOABioAge Labs, Inc.$18.71-2.22%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.14-8.15%

CABACabaletta Bio, Inc.

CABACabaletta Bio, Inc.$3.61+0.56%

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$2.85-1.72%

MASS908 Devices Inc.

MASS908 Devices Inc.$7.30-3.18%

SENSSenseonics Holdings, Inc.

SENSSenseonics Holdings, Inc.$5.82+5.82%

NEONeoGenomics, Inc.

NEONeoGenomics, Inc.$8.36+1.21%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.02+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.70-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$78.95+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.07-0.02%

AURAurora Innovation

AURAurora Innovation$8.18-0.03%

Questions About ACRS

What is the current price of Aclaris Therapeutics?

Aclaris Therapeutics is trading at $4.82 per share.

What is the 52-week range for Aclaris Therapeutics?

Over the past 52 weeks, Aclaris Therapeutics has traded between $1.16 and $5.14.

How much debt does Aclaris Therapeutics have?

As of the most recent reporting period, Aclaris Therapeutics reported total debt of $1.99M.

How much cash does Aclaris Therapeutics have on hand?

Aclaris Therapeutics reported $28.66M in cash and cash equivalents in its most recent financial results.

What is Aclaris Therapeutics’s dividend yield?

Aclaris Therapeutics does not currently have a dividend yield.

Aclaris Therapeutics

Aclaris Therapeutics Financials at a Glance

ACRS News

Why Aclaris Therapeutics Stock Soared Nearly 6% on Thursday

Why Aclaris Therapeutics Topped the Market on Tuesday

Why Aclaris Therapeutics Is Crashing Today

Why Aclaris Therapeutics Stock Skyrocketed More Than 200% Today

Here's Why Aclaris Therapeutics Stock Collapsed Today

Could These 2 Biotech Stocks Really Double Your Money?

Why Aclaris Therapeutics, Inc. Stock Is Down Today

The Best IPOs of 2015

ACRS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aclaris Therapeutics

ACRS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aclaris Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACRS

What is the current price of Aclaris Therapeutics?

What is the 52-week range for Aclaris Therapeutics?

How much debt does Aclaris Therapeutics have?

How much cash does Aclaris Therapeutics have on hand?

What is Aclaris Therapeutics’s dividend yield?

Premium Investing Services